Company Quick10K Filing
American Bio Medica
10-Q 2021-03-31 Filed 2021-05-20
10-K 2020-12-31 Filed 2021-04-15
S-1 2020-12-29 Public Filing
10-Q 2020-09-30 Filed 2020-11-16
10-Q 2020-06-30 Filed 2020-09-15
10-Q 2020-03-31 Filed 2020-07-31
10-K 2019-12-31 Filed 2020-06-26
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-04-12
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-03-31 Filed 2013-05-14
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-03-25
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-12
10-Q 2010-03-31 Filed 2010-05-14
10-K 2009-12-31 Filed 2010-03-30
8-K 2021-02-05 Officers
8-K 2020-12-18 Shareholder Vote
8-K 2020-12-09 Enter Agreement, Sale of Shares, Exhibits
8-K 2020-11-16
8-K 2020-09-15
8-K 2020-08-20
8-K 2020-07-31
8-K 2020-06-26
8-K 2020-05-29
8-K 2020-05-14
8-K 2020-04-15
8-K 2020-03-18
8-K 2020-02-20
8-K 2020-01-07
8-K 2019-11-14
8-K 2019-08-14
8-K 2019-06-20
8-K 2019-05-23
8-K 2019-05-20
8-K 2019-04-16
8-K 2019-02-25
8-K 2018-12-20
8-K 2018-06-21
8-K 2018-03-02
8-K 2018-01-05

American Bio Medica Financials

ABMC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
PALTALK, INC. (PALT)
Better World Acquisition Corp. (BWACW)
East Stone Acquisition Corp (ESSCW)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
FUELCELL ENERGY INC (FCELB)
3D Total Solutions (DTLS)
3DX Industries (DDDX)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2222936089155636465214474333524874332241589717822115613613815036927659113549915
Accounts Receivable1,0791,1388839401,2428109071,054952875909742782814648859802672789720721556611482521348421512546452392393492
Inventory3,2213,1763,2393,3133,0792,5712,4782,4812,1762,0711,9661,9291,8521,7221,8121,8241,8481,7461,6211,6101,5561,5821,5031,4501,4621,4731,3881,2611,2501,019973825890
PP&E1,3321,3411,3041,2761,2254,4631,1751,1901,1354,4781,0621,0409763,9179579429233,9308878668443,9308058238103,9747747547363,974699681663
Assets5,8895,8925,6365,6945,7204,7795,1585,2664,5254,9664,7434,3904,3384,0784,2514,4294,2163,7973,6383,5923,5493,3713,2783,1353,1432,8912,8772,7762,8082,4752,3162,1652,246
Accounts Payable6006846318771,0271,016698648762597633462510410423508429373470376305304304278306374430349459359521555606
Long-Term Debt1,5381,5181,4801,4531,4351,4045535231,2862,0672,0772,1472,2182,2722,1311,9771,7461,8181,8611,7641,8001,6811,6641,5271,6451,7461,7421,6461,5371,4911,554
Liabilities3,5083,5203,2663,5233,8043,4153,8964,2733,7293,6283,3623,0403,1403,1083,0253,2783,0592,8362,5132,4942,3712,3462,3732,2402,2872,2682,4992,5382,7462,6212,6832,5842,809
Stockholders' Equity2,3812,3722,3702,1711,9161,3641,2629937961,3381,3811,3501,1989701,2261,1511,1579611,1251,0981,1781,02590589585662337823872-146-367-419-563
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue2,4862,3652,3742,2962,2832,3022,1252,3802,2572,1322,0431,8111,7501,6811,5021,7681,5901,4571,4701,5051,4171,2171,3161,3061,3549391,0411,069878923958895
Cost of Revenue1,3351,3991,3771,3341,3921,8541,3391,4111,3511,2211,1661,0201,0271,010802919823919840796806678751741788638669632514617652536
Gross Profit1,151966997962891448786969906911877791723671700849767538630709611539565565566301372437364306306359
R&D5761535254456312431515246459245295145235455284846402623251920192023
SG&A9198809171,0791,0669051,0851,0658771,030769735755804724829679702667640643612586564535506553511476461441417
Tax154-50012-3414010002101201-21040020
Net Income123-28-15-206-264-565-424-294-2131459181-211-238-45-83-2-2031-44-88-215-132-71-49-293-267-147-202-240-56-144
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating160258-155361-743-26950718726-9-106177-861412517213056-47163-56-110-55292-149
Cash Investing-80-32-211-11-4624-1-11-10-43-2-5-7-7-3-30-24-9-42-6-7-8000
Cash Financing-80-15589-273666369-523-311-89568-4037-216-184-2317243-9736-119118101-4-111-4765